HOUSE-BILL 4752: H.R.4752 - Reducing Hereditary Cancer Act
AI-Powered Summary
HOUSE-BILL 4752 aims to enhance healthcare access for individuals with a family history of hereditary cancer gene mutations by mandating coverage for genetic testing, preventive surgeries, and screenings. The legislation addresses major themes of healthcare rights, privacy, and equal protection under the law. Key provisions include the requirement for insurance coverage of germline mutation testing, risk-reducing surgeries, and evidence-based screenings, which are designed to empower individuals to make informed health decisions and improve health outcomes through early detection. Implementation will require insurance providers to adapt their policies to comply with the new coverage mandates, although a specific timeline for these changes is not detailed in the bill. Potential impacts include improved health outcomes for at-risk individuals, but there are constitutional concerns regarding privacy and equitable access that may arise, particularly if certain demographic groups face barriers to these services.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill enhances healthcare access for individuals with hereditary cancer risks, promoting public health and welfare. It aligns with constitutional principles by supporting the right to health care, even though such a right is not explicitly guaranteed in the Constitution.
Key Individual Rights
- Right to Health Care
- Equal Protection under the Law
- Privacy Rights regarding Genetic Information
Constitutional Provisions
- General Welfare Clause (Article I, Section 8)
- Equal Protection Clause (14th Amendment)
- Privacy Rights (implied through various amendments)
Potential Constitutional Challenges
While the bill supports individual rights, there may be challenges regarding the potential misuse of genetic information and discrimination based on genetic predispositions. The effectiveness of existing protections under the Genetic Information Nondiscrimination Act (GINA) could be scrutinized.
Summary
HOUSE-BILL 4752 significantly impacts individuals by providing necessary healthcare interventions for those at risk of hereditary cancers. It promotes equitable access to genetic testing and preventive surgeries, addressing disparities among different demographic groups. However, it also necessitates careful consideration of privacy and discrimination issues to ensure that the rights of all individuals are protected.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 4752 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
July 23, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat